AAV GENE THERAPY SEQUENCING

Adeno-associated virus (AAV) gene therapy sequencing enables you to verify the quality and integrity of packaged AAV vectors, including inverted terminal repeat (ITR) regions, measure AAV expression after infection, monitor host response, and much more.

Whether you need to sequence a packaged AAV product, AAV plasmid, or interested in post-infection solutions, we offer custom, in-depth AAV gene therapy sequencing for your complex AAV applications. Our solutions combine next generation sequencing (NGS) using the latest technologies, such as PacBio® long-read (>10kb) or Illumina® short-read sequencing, with our proprietary QC process to provide you with reliable, accurate results and streamline your AAV gene therapy research.

 

What is AAV Gene Therapy?

Adeno-associated viruses (AAV) are the optimal vehicle for, and leading viral vector used in in vivo gene therapy clinical trials due to their high efficiency and enhanced safety in humans.

 

NGS SOLUTIONS FOR AAV GENE THERAPY

Confirm Plasmid Sequences

Utilize Azenta's© short-read amplicon sequencing for highly-accurate confirmation of AAV plasmid inserts, or confirm full-length recombinant AAV (rAAV) vector integrity at the single-molecule level with long-read amplicon sequencing.

Validate Packaged Material

Sequence-confirm rAAV vectors and identify DNA contaminants in AAV library preparation by employing the power of Azenta's© short- and long-read whole genome sequencing solutions.

Quantify AAV Expression

Employ Azenta's© qPCR, targeted sequencing, or RNA sequencing solutions at the RUO and CLIA levels to measure AAV expression of the target gene after infection.

Monitor Host Response

Stratify and characterize host-immune response during and after infection with Azenta's© suite of RNA sequencing solutions, or use novel approaches including single-cell sequencing and spatial genomics.

Learn more about Azenta's© additional adeno-associated virus (AAV) services for your cell and gene therapy research.

AAV GENOME SEQUENCING WORKFLOW

  • 1. Sample
    Preparation

  • 2. Library
    Preparation

  • 3. Sequencing

  • 4. Bioinformatics
    Analysis

NGS AAV FEATURES & BENEFITS

  • Superior Data Quality
    Exceeding manufacturer’s benchmarks

  • Real-Time Project Updates
    Through our online system

  • Ph.D.-Level Support
    At every step

  • Trusted partner supporting over 150 top global pharmaceutical and biotech customers in their cell and gene therapy research

  • Optimized, automated, and scalable workflows with stringent quality control producing high-quality, consistent results

  • RUO and CLIA-grade, high-capacity and high-throughput sequencing for projects of virtually any size and sample type

  • Customized and extensive bioinformatics solutions with interactive, hands-on analysis

AAV NEXT GENERATION SEQUENCING TECHNICAL RESOURCES

  • PUBLICATION
    Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras

    Discover how researchers utilized single molecule, real-time (SMRT®) sequencing to profile rAAV-packaged genomes and assess full-length integrity for rAAV quality control.

  • PUBLICATION
    Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing

    In this study, learn how short-read sequencing technology can extensively characterize the rAAV genome while simultaneously detecting the presence of DNA contaminants.

  • WEBINAR
    Novel Sequencing & Synthetic Solutions for AAV-Based Gene Therapy Research

    Adeno-associated virus (AAV) vectors are an optimal vehicle for gene therapy delivery, but can present challenges for researchers. In this interview-style webinar first aired at the PacBio Global Virtual Summit 2020, Azenta presents proprietary sequencing and synthesis solutions to overcome the obstacles presented by AAV-based gene therapy.

  • WORKSHOP & ROUNDTABLE DISCUSSION
    A Comprehensive Guide to Using AAV Vectors in Gene Therapy

    Working with AAV vectors can be challenging. In this on-demand workshop & roundtable discussion, you’ll gain a better understanding of the AAV development pipeline for gene therapy research and learn how to optimize upstream and downstream processes including AAV synthesis, sequencing, bioinformatics, and storage.

 

NGS PLATFORMS

For information on our NGS platforms as well as recommended configurations of your projects, please visit the NGS Platforms page. Azenta does not guarantee data output or quality for sequencing-only projects.

Illumina
PacBio
10x Genomics
NanoString
Nanopore
Olink


STREAMLINE YOUR PATH TO DISCOVERY

Gene-to-Discovery Solutions

AAV Packaging, Custom mRNA Synthesis, Lentivirus Packaging, Recombinant Antibody Production


Related Services

How To Order


Email | Phone +49 (0)341 520 122-41

 
GENEWIZ from Azenta Life Sciences

European Genomics Headquarters

GENEWIZ Germany GmbH, Bahnhofstrasse 86, 04158 Leipzig | service.europe@genewiz.com | +49 (0)341 520 122-41

Copyright © 2024 All Rights Reserved.